| アブストラクト | BACKGROUND: To perform an international comparison and analysis of celecoxib spontaneous adverse event reports (AERs) from Canada, Australia and the United States, focusing on gastrointestinal, renal and cardiovascular events. This study also examined concomitant medicines use which may have potentiated the risk of the reported adverse events. Research, design and methods: Three databases were searched for spontaneous AERs associated with celecoxib, submitted within the past 10 years: Australian Therapeutic Goods Administration Database of Adverse Event Notifications; Canada Vigilance Adverse Reaction Online Database; and the United States Food and Drug Administration Adverse Event Reporting System Database. Analysis of the AERs focussed on the identification of gastrointestinal, cardiovascular and renal adverse events and concomitant medications suspected of potentiating adverse event risks. RESULTS: A total of 24,232 celecoxib AERs were identified. Gastrointestinal disorders were the most frequently reported adverse events at the system organ class (SOC) level in the AERs. A large number of AERs documented the use of potentially inappropriate concomitant medicines which may have increased the risk of the reported adverse events. CONCLUSIONS: The large number of reports that involved a concomitant medicine that was in contravention with prescribing guidelines indicates an increased need for efforts to support the safe prescribing of celecoxib. |
|---|
| 投稿日 | 2019/4/2 |
|---|
| 投稿者 | Baselyous, Youanna; De Cocinis, Michael; Ibrahim, Mohammed; Kalra, Alisa; Yacoub, Rachel; Ahmed, Rana |
|---|
| ジャーナル名 | Expert opinion on drug safety |
|---|
| 組織名 | a Discipline of Pharmacy, School of Health and Biomedical Sciences , RMIT;University , Bundoora , Australia. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/30929580/ |
|---|
